Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP168225.RApgIuYI7Nq5uHKqBd6RoVoH8s64F9Nek8ngVGV477yBU130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168225.RApgIuYI7Nq5uHKqBd6RoVoH8s64F9Nek8ngVGV477yBU130_provenance.
• NP378844.RAuTK12ryyeToFFkRnrfijNLSobOysl5rlvHMZqwWggjA130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378844.RAuTK12ryyeToFFkRnrfijNLSobOysl5rlvHMZqwWggjA130_provenance.
• NP136752.RAf8Xjo8a0pG0TVz6vE_XYjWmIAPTDu0FTK5z6tZKWhDs130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP136752.RAf8Xjo8a0pG0TVz6vE_XYjWmIAPTDu0FTK5z6tZKWhDs130_provenance.
• NP658402.RAcV2G6lDlU4UekW-r6Rg0pSCe_Erdw-BBZU_rqe2GAxk130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658402.RAcV2G6lDlU4UekW-r6Rg0pSCe_Erdw-BBZU_rqe2GAxk130_provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP136779.RApkkZ8FPn27JDvuduA8UTJpZVjuweCk7vdrGmYoH2oBQ130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP136779.RApkkZ8FPn27JDvuduA8UTJpZVjuweCk7vdrGmYoH2oBQ130_provenance.
• NP109254.RAbdp48WXVM1i-XTmHzdNhWl6w8_7aVY-G419pikI0LQ0130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109254.RAbdp48WXVM1i-XTmHzdNhWl6w8_7aVY-G419pikI0LQ0130_provenance.
• NP87590.RAhIJVP1_iF7BkvnXydPfpE5-UJ2xNyY6oZx5cj5Ow0z0130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87590.RAhIJVP1_iF7BkvnXydPfpE5-UJ2xNyY6oZx5cj5Ow0z0130_provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP87662.RAC6b98vqaCNRDQOAVreL2auB5agQ-apVSJ8BR7D-wlc4130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87662.RAC6b98vqaCNRDQOAVreL2auB5agQ-apVSJ8BR7D-wlc4130_provenance.
• NP109257.RAATN2yLGa289pxdhHeyZcr-npt8B9c-2BXZgaFSZMJKw130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109257.RAATN2yLGa289pxdhHeyZcr-npt8B9c-2BXZgaFSZMJKw130_provenance.
• NP620896.RAWe8DuHV7gCGmyvnkwkUOpyFzFS1PWVtsu3sL-8uy09g130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620896.RAWe8DuHV7gCGmyvnkwkUOpyFzFS1PWVtsu3sL-8uy09g130_provenance.
• NP109252.RAsr37ViyRYEH8m6KLvEbNUuQLOYFG_-kLDlKFYxBJnqo130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109252.RAsr37ViyRYEH8m6KLvEbNUuQLOYFG_-kLDlKFYxBJnqo130_provenance.
• NP109255.RAvKjsXVIIhKiYXJXyRUzf4TuLPJrmM2k_zTkF2dZaXUg130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109255.RAvKjsXVIIhKiYXJXyRUzf4TuLPJrmM2k_zTkF2dZaXUg130_provenance.
• NP87670.RAO6-wXpH1QszweHikaKlptVhnkhjGJbmMrrq2ki1xwUM130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87670.RAO6-wXpH1QszweHikaKlptVhnkhjGJbmMrrq2ki1xwUM130_provenance.
• NP87584.RA4JRASYzbMPzAL4eJTh9qE1mpo-LyEiqr1ZRjGv9D0hM130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87584.RA4JRASYzbMPzAL4eJTh9qE1mpo-LyEiqr1ZRjGv9D0hM130_provenance.
• NP128396.RA1xNfrIEQD1xi9-UErmxQL2B8ZI98eri2a6HenZMF71Q130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP128396.RA1xNfrIEQD1xi9-UErmxQL2B8ZI98eri2a6HenZMF71Q130_provenance.
• NP101026.RAMR33XJgBUxhUH4QYwIcOHXn6bkGIZR0X7tHlRaKJ0mU130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101026.RAMR33XJgBUxhUH4QYwIcOHXn6bkGIZR0X7tHlRaKJ0mU130_provenance.
• NP127640.RAHfTFh8_coN1QBgVhC-6uzHPi62HM8lr6Ie80ubDTj0o130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP127640.RAHfTFh8_coN1QBgVhC-6uzHPi62HM8lr6Ie80ubDTj0o130_provenance.
• NP505106.RAwk8NX2EMBokTxFWM4FTJItpy5gUrM581QQHDuBUm144130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505106.RAwk8NX2EMBokTxFWM4FTJItpy5gUrM581QQHDuBUm144130_provenance.
• NP505149.RAPcDWIHoVTYLJTN9FNa3nYIn_moqw8iHT21HhZXr6klU130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505149.RAPcDWIHoVTYLJTN9FNa3nYIn_moqw8iHT21HhZXr6klU130_provenance.
• NP656659.RAK9LtwtvsYXn3vR7-9erUjrD2hCn95ovM8L8RqR1ZaxA130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP656659.RAK9LtwtvsYXn3vR7-9erUjrD2hCn95ovM8L8RqR1ZaxA130_provenance.
• NP109256.RAN_sPpbh08_SYAE7IHGUiyGvbfoO33Wqm4tULkonyubg130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109256.RAN_sPpbh08_SYAE7IHGUiyGvbfoO33Wqm4tULkonyubg130_provenance.
• NP620897.RAMytxHbWrMkQ6waMaMWdhWEncO2LL7qUExi7H6shBzic130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620897.RAMytxHbWrMkQ6waMaMWdhWEncO2LL7qUExi7H6shBzic130_provenance.
• NP620898.RA9F0eRb2JgLsU4l9ELuNDTqr-0dQNRg9j6XCXgVQFDyI130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620898.RA9F0eRb2JgLsU4l9ELuNDTqr-0dQNRg9j6XCXgVQFDyI130_provenance.
• NP109253.RA7taOCpcW2nM_d-2QyPhMhDp9uqyBdyVQJE1IvQ9GhpA130_assertion description "[Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109253.RA7taOCpcW2nM_d-2QyPhMhDp9uqyBdyVQJE1IvQ9GhpA130_provenance.